CE-MICROARRAY

Cavity Enhanced Microarray as an Ultra-sensitive Tool to aid Sepsis Diagnosis

Coordinatore	UNIVERSITY OF TEESSIDE    more  Organization address address: BOROUGH ROAD city: MIDDLESBROUGH postcode: TS1 3BA contact info Titolo: Ms. Nome: Kirsty Cognome: Jarvis Email: send email Telefono: +44 1642342508 Fax: +44 1642384411
Nazionalità Coordinatore	United Kingdom [UK]
Totale costo	1˙532˙439 €
EC contributo	1˙139˙066 €
Programma	FP7-SME Specific Programme "Capacities": Research for the benefit of SMEs
Code Call	FP7-SME-2013
Funding Scheme	BSG-SME
Anno di inizio	2014
Periodo (anno-mese-giorno)	2014-02-01   -   2016-01-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	UNIVERSITY OF TEESSIDE  Organization address address: BOROUGH ROAD city: MIDDLESBROUGH postcode: TS1 3BA contact info Titolo: Ms. Nome: Kirsty Cognome: Jarvis Email: send email Telefono: +44 1642342508 Fax: +44 1642384411	UK (MIDDLESBROUGH)	coordinator	14˙586.00
2	ANASYST LTD  Organization address address: BOROUGH ROAD GRADUATE RESEARCH SCHOOL TEESSIDE UNIVERSITY city: MIDDLESBROUGH postcode: TS1 3BA contact info Titolo: Dr. Nome: Roger Cognome: Duggan Email: send email Telefono: +44 1642 342532	UK (MIDDLESBROUGH)	participant	226˙684.00
3	NEHIR BIYOTEKNOLOJI AR-GE HIZMETLERI DANISMANLIK BILISIM PAZARLAMA SANAYI TICARET LTD STI  Organization address address: odtu-ostim teknokent uzaycagi caddesi 1308 SOK NO:6B8 city: ANKARA contact info Titolo: Mr. Nome: Serhat Cognome: Sevli Email: send email Telefono: +90 5356287887	TR (ANKARA)	participant	219˙875.00
4	BIAMETRICS GMBH  Organization address address: AUF DER MORGENSTELLE 18 city: TUBINGEN postcode: 72076 contact info Titolo: Dr. Nome: Günther Cognome: Proll Email: send email Telefono: +49 15129164874	DE (TUBINGEN)	participant	212˙566.00
5	ANALOX SENSOR TECHNOLOGY LTD  Organization address address: ELLERBECK COURT STOKESLEY 15 city: STOKESLEY NORTH YORKSHIRE postcode: TS9 5PT contact info Titolo: Mr. Nome: Andrew Cognome: Watson Email: send email Telefono: +44 1642715900	UK (STOKESLEY NORTH YORKSHIRE)	participant	203˙925.00
6	UNION PLASTIC S.A.S  Organization address address: ZA ROBERT city: SAINT DIDIER EN VELAY postcode: 43140 contact info Titolo: Mr. Nome: Philippe Cognome: Roulet Email: send email Telefono: +33 471617140	FR (SAINT DIDIER EN VELAY)	participant	112˙109.00
7	YORKSHIRE PHOTONIC TECHNOLOGY LIMITED  Organization address address: HOLDSWORTH ROAD UNIT HM14 HOLMFIELD MILLS city: HALIFAX postcode: HX3 6SN contact info Titolo: Dr. Nome: Ashley Cognome: Knowles Email: send email Telefono: +44 1422243603	UK (HALIFAX)	participant	104˙065.00
8	OSAUHING EESTI INNOVATSIOONI INSTITUUT  Organization address address: SEPAPAJA 6 city: TALLINN postcode: 11415 contact info Titolo: Mr. Nome: Lauri Cognome: Nirgi Email: send email Telefono: +37 2610 1230	EE (TALLINN)	participant	27˙990.00
9	ALBERT-LUDWIGS-UNIVERSITAET FREIBURG  Organization address address: FAHNENBERGPLATZ city: FREIBURG postcode: 79085 contact info Titolo: Dr. Nome: Günter Cognome: Roth Email: send email Telefono: +49 76120373244	DE (FREIBURG)	participant	17˙266.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Sepsis is a life-threatening illness caused by the body’s overreaction to an infection and can be triggered either directly by infection or may occur after medical treatment or surgery.The mortality rate in patients admitted to hospital with severe sepsis is 28-50% and it remains the most prevalent cause of death in non-coronary Intensive Care Units (ICUs ). It is estimated that in the US ~$17 billion were spent annually treating sepsis in patients and a similar amount is spent across the EU. To reduce costs and provide better treatment to patients, early, accurate diagnosis is critically important.

The CE-microArray project will utilize existing technology from clinical chemistry, microplate readers and cavity enhanced spectroscopy in a truly novel way to develop more sensitive, accurate, faster and more useful diagnostic platform. The project consortium comprises experienced SMEs from across Europe who have developed the concept but do not have the capability to undertake the required Research and Development to produce working prototypes in preparation for commercialization. To do this they require funding to pay third party R&D specialists to undertake the R&D. The project aims to produce a solution based on colorimetric detection that will be up to 100 times more sensitive, reducing the damage to patients with sepsis, allow sensitive and accurate detection of an increased range of biomarkers at lower cost and higher throughput. The market opportunity is estimated be greater than €1 billion and will bring a cumulative profit of ~€38 million to the SME consortium over 5 years.'